Cyclophosphamide - NDC Database (Page 5)
130 records found
Page:
68001-442 Oct 19, 2020
Cyclophosphamide 500 mg/25ml Intravenous; Oral Injection, Powder, for Solution by Bluepoint Laboratories
Cyclophosphamide 500 mg/25ml Intravenous; Oral Injection, Powder, for Solution by Bluepoint Laboratories
68001-443 Oct 19, 2020
Cyclophosphamide 1 g/50ml Intravenous; Oral Injection, Powder, for Solution by Bluepoint Laboratories
Cyclophosphamide 1 g/50ml Intravenous; Oral Injection, Powder, for Solution by Bluepoint Laboratories
68001-444 Oct 19, 2020
Cyclophosphamide 2 g/100ml Intravenous; Oral Injection, Powder, for Solution by Bluepoint Laboratories
Cyclophosphamide 2 g/100ml Intravenous; Oral Injection, Powder, for Solution by Bluepoint Laboratories
68001-563 Feb 20, 2023
Cyclophosphamide 200 mg/ml Intravenous Injection, Solution by Bluepoint Laboratories
Cyclophosphamide 200 mg/ml Intravenous Injection, Solution by Bluepoint Laboratories
68001-564 Apr 10, 2023
Cyclophosphamide 200 mg/ml Intravenous Injection, Solution by Bluepoint Laboratories
Cyclophosphamide 200 mg/ml Intravenous Injection, Solution by Bluepoint Laboratories
68001-565 Apr 10, 2023
Cyclophosphamide 200 mg/ml Intravenous Injection, Solution by Bluepoint Laboratories
Cyclophosphamide 200 mg/ml Intravenous Injection, Solution by Bluepoint Laboratories
68001-694 Mar 15, 2026
Cyclophosphamide 500 mg/25ml Intravenous; Oral Injection, Powder, for Solution by Bluepoint Laboratories
Cyclophosphamide 500 mg/25ml Intravenous; Oral Injection, Powder, for Solution by Bluepoint Laboratories
68001-695 Mar 15, 2026
Cyclophosphamide 1 g/50ml Intravenous; Oral Injection, Powder, for Solution by Bluepoint Laboratories
Cyclophosphamide 1 g/50ml Intravenous; Oral Injection, Powder, for Solution by Bluepoint Laboratories
68001-696 Mar 15, 2026
Cyclophosphamide 2 g/100ml Intravenous; Oral Injection, Powder, for Solution by Bluepoint Laboratories
Cyclophosphamide 2 g/100ml Intravenous; Oral Injection, Powder, for Solution by Bluepoint Laboratories
70121-1238 May 31, 2018
Cyclophosphamide 500 mg/25ml Intravenous; Oral Injection, Powder, for Solution by Amneal Biosciences LLC
Cyclophosphamide 500 mg/25ml Intravenous; Oral Injection, Powder, for Solution by Amneal Biosciences LLC
70121-1239 May 31, 2018
Cyclophosphamide 1 g/50ml Intravenous; Oral Injection, Powder, for Solution by Amneal Biosciences LLC
Cyclophosphamide 1 g/50ml Intravenous; Oral Injection, Powder, for Solution by Amneal Biosciences LLC
70121-1240 May 31, 2018
Cyclophosphamide 2 g/100ml Intravenous; Oral Injection, Powder, for Solution by Amneal Biosciences LLC
Cyclophosphamide 2 g/100ml Intravenous; Oral Injection, Powder, for Solution by Amneal Biosciences LLC
70436-105 Mar 26, 2025
Cyclophosphamide 500 mg/25ml Intravenous Injection, Powder, for Solution by Slate Run Pharmaceuticals, LLC
Cyclophosphamide 500 mg/25ml Intravenous Injection, Powder, for Solution by Slate Run Pharmaceuticals, LLC
70436-106 Mar 26, 2025
Cyclophosphamide 1 g/50ml Intravenous Injection, Powder, for Solution by Slate Run Pharmaceuticals, LLC
Cyclophosphamide 1 g/50ml Intravenous Injection, Powder, for Solution by Slate Run Pharmaceuticals, LLC
70436-107 Mar 26, 2025
Cyclophosphamide 2 g/100ml Intravenous Injection, Powder, for Solution by Slate Run Pharmaceuticals, LLC
Cyclophosphamide 2 g/100ml Intravenous Injection, Powder, for Solution by Slate Run Pharmaceuticals, LLC
70860-218 Dec 11, 2020
Cyclophosphamide 200 mg/ml Intravenous Injection, Solution by Athenex Pharmaceutical Division, LLC.
Cyclophosphamide 200 mg/ml Intravenous Injection, Solution by Athenex Pharmaceutical Division, LLC.
72572-083 May 21, 2008
Cyclophosphamide 2 g/100ml Intravenous; Oral Injection, Powder, for Solution by Civica, Inc.
Cyclophosphamide 2 g/100ml Intravenous; Oral Injection, Powder, for Solution by Civica, Inc.
72572-085 May 21, 2008
Cyclophosphamide 1 g/50ml Intravenous; Oral Injection, Powder, for Solution by Civica, Inc.
Cyclophosphamide 1 g/50ml Intravenous; Oral Injection, Powder, for Solution by Civica, Inc.
Page:
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.